bretolap tablet - Lapatinib (250mg) medicine

Bretolap Tablet (Lapatinib 250mg): Complete Guide to Uses, Side Effects, and Safety

No reviews yet
🏭 Alkem Laboratories Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 22, 2026
⚠️ Hepatotoxicity Risk 🤰 Pregnancy Category This medicine can cause harm to the unborn baby. It is not recommended during pregnancy. Effective contraception should be used during treatment and for at least one week after the last dose. If pregnancy occurs, consult your doctor immediately. 📋 Prescription Required 💊 Generic Available
Medically Reviewed
12 min read
Evidence: Well-established for approved indications.
Reviewed by
SaathiMed Expert Panel | Oct 22, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • More than six loose stools in a day or diarrhea that does not improve with treatment.
  • Yellowing of the eyes or skin, dark urine, or right upper abdominal pain.
  • Shortness of breath, swelling of the legs, or sudden weight gain.
  • Chest pain, palpitations, or fainting.
  • Severe skin rash with blistering or peeling.
  • New or worsening cough, fever, or difficulty breathing.
  • Fever with chills or sore throat suggesting infection.
  • Unusual bleeding or bruising.
  • Severe headache with confusion or vision changes.
  • Inability to eat or drink, or signs of dehydration such as dizziness or reduced urine output.

If experiencing severe symptoms, call emergency services immediately.

What is bretolap tablet used for?

This medicine is a targeted anticancer tablet containing lapatinib 250 mg. It is used for HER2-positive metastatic breast cancer in combination with other medicines. It works by blocking EGFR and HER2 receptors on cancer cells. It can cause diarrhea, rash, liver problems, and heart problems, so regular monitoring is essential.

  • Generic Name: Lapatinib
  • Manufacturer: Alkem Laboratories Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 bretolap tablet के बारे में (Hindi Summary)

उपयोग: यह दवा लैपेटिनिब 250 मिलीग्राम की एक टैबलेट है जिसका उपयोग HER2-पॉजिटिव मेटास्टेटिक ब्रेस्ट कैंसर के इलाज में किया जाता है। यह एक टार्गेटेड कैंसर थेरेपी है जो कैंसर कोशिकाओं में EGFR और HER2 रिसेप्टर्स को ब्लॉक करती है, जिससे कैंसर कोशिकाओं की वृद्धि रुकती है। यह दवा अकेले नहीं, बल्कि कैपेसिटाबिन या लेट्रोज़ोल जैसी अन्य दवाओं के साथ दी जाती है। यह दवा केवल कैंसर रोग विशेषज्ञ की देखरेख में ही लेनी चाहिए। इसे गर्भवती महिलाओं, स्तनपान कराने वाली महिलाओं और गंभीर लिवर रोग वाले मरीजों को नहीं लेना चाहिए।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में दस्त, जी मिचलाना, उल्टी, त्वचा पर दाने, मुँह के छाले, थकान, भूख न लगना और सिरदर्द शामिल हैं। दस्त गंभीर हो सकते हैं और शरीर में पानी की कमी कर सकते हैं, इसलिए इन्हें तुरंत डॉक्टर को बताना चाहिए। कुछ मरीजों में हाथ-पैर सिंड्रोम हो सकता है जिसमें हथेलियों और तलवों पर लालिमा, सूजन और दर्द होता है। लिवर की जाँच और दिल की जाँच नियमित रूप से करानी चाहिए क्योंकि यह दवा लिवर और हृदय को नुकसान पहुँचा सकती है।

सुरक्षा सलाह: यह दवा केवल कैंसर रोग विशेषज्ञ की सलाह से ही लें। दवा की खुराक खुद से कम या ज्यादा न करें। इसे हर दिन एक ही समय पर लें, खाने के साथ या बिना खाने के, लेकिन अंगूर या अंगूर के जूस के साथ कभी न लें। टैबलेट को पानी के साथ पूरा निगलें, चबाएं या तोड़ें नहीं। दस्त होने पर ओआरएस का घोल पिएं और अगर एक दिन में चार से ज्यादा बार दस्त हों तो डॉक्टर को बताएं। इलाज के दौरान गर्भधारण से बचें और स्तनपान न कराएं। लिवर, दिल और खून की नियमित जाँच कराते रहें। अगर आँखों या त्वचा का रंग पीला पड़े, पेशाब गहरा हो, सांस फूले या पैरों में सूजन आए तो तुरंत डॉक्टर से मिलें।

💡 Did You Know? India is the largest provider of generic medicines globally, supplying over 50% of global vaccine demand.

💊 bretolap tablet Uses & Benefits

[{"condition":"HER2-positive metastatic breast cancer","description":"Used in combination with capecitabine for patients with advanced or metastatic HER2-positive breast cancer who have received prior therapy including an anthracycline, a taxane, and trastuzumab.","evidence":"Well-established"},{"condition":"Hormone receptor-positive, HER2-positive metastatic breast cancer","description":"Used in combination with letrozole for postmenopausal women with hormone receptor-positive metastatic breast cancer that overexpresses HER2 and for whom hormonal therapy is indicated.","evidence":"Well-established"},{"condition":"HER2-positive inflammatory breast cancer","description":"Sometimes used as part of a treatment plan for inflammatory breast cancer that is HER2-positive, though this is less common and depends on the clinical situation.","evidence":"Limited"}]

Off-label uses: [{"condition":"Other HER2-positive solid tumors","description":"Occasionally used off-label in HER2-positive cancers such as gastric or gastroesophageal junction cancer, but this is not a standard approved use.","evidence":"Limited"},{"condition":"EGFR-overexpressing tumors","description":"Rarely used off-label in some EGFR-driven cancers, but evidence is not strong enough for routine use.","evidence":"Limited"}]

Primary treatment for: HER2-positive metastatic breast cancer

Also treats: Hormone receptor-positive, HER2-positive metastatic breast cancer, HER2-positive inflammatory breast cancer

📋 Drug Information

Generic Name(s)Lapatinib
Brand NameBretolap Tablet
ManufacturerAlkem Laboratories Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassTyrosine kinase inhibitors
Route of AdministrationOral
StorageStore at room temperature between 15°C and 30°C (59°F to 86°F). Keep the tablets in their original container, tightly closed, and protect them from light and moisture. Do not store in the bathroom. Keep out of reach of children and pets.
Shelf LifeThe shelf life is typically 24 months from the date of manufacture, but check the expiry date on the pack. Do not use after the expiry date.
WHO GuidelineNot established from the available information. Treatment should follow institutional and national oncology guidelines.
ICMR GuidelineNot established from the available information. Consult your oncologist for guideline-based care.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Always check liver function tests before starting this medicine and repeat them every 4 to 6 weeks, or more often if abnormal.
2
Assess left ventricular ejection fraction before treatment and every 8 to 12 weeks during treatment to detect cardiotoxicity early.
3
Start antidiarrheal treatment at the first sign of loose stools and advise patients to drink plenty of fluids to prevent dehydration.
4
Review all concomitant medicines for CYP3A4 interactions and adjust doses accordingly.
5
Advise patients to avoid grapefruit and grapefruit juice completely while on this medicine.
6
Educate patients about the signs of liver injury and heart failure, and instruct them to report these immediately.
7
Use effective contraception during treatment and for at least one week after the last dose in women of childbearing potential.
8
Consider dose reduction if the patient experiences severe diarrhea, rash, or other significant side effects.
9
Monitor for hand-foot syndrome and recommend moisturizers and avoidance of tight footwear.
10
Coordinate care with a cardiologist if the patient has pre-existing heart disease or develops cardiac symptoms.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
HER2-positive breast cancer
This medicine is approved for this condition.
Likely Use
❌
Diarrhea
Diarrhea is a side effect, not a reason to use this medicine.
Not Primary
❌
Rash
Rash is a side effect, not a reason to use this medicine.
Not Primary
❌
Fever
This medicine is not a fever reducer.
Not Primary
❌
Pain
This medicine is not a painkiller.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionAbsorption of this medicine after oral administration is variable and incomplete. The absolute bioavailability is not well established from the available information. Food can increase the absorption of this medicine, and taking it with a high-fat meal may increase exposure. It is usually taken at the same time each day, with or without food, but grapefruit should be avoided.
DistributionThis medicine is highly bound to plasma proteins, mainly albumin and alpha-1 acid glycoprotein. It distributes into tissues, but specific volume of distribution data are not well established from the available information.
Protein BindingGreater than 99% bound to plasma proteins, primarily albumin and alpha-1 acid glycoprotein.
MetabolismThis medicine is extensively metabolized in the liver, mainly by cytochrome P450 enzymes CYP3A4 and CYP3A5, with minor contributions from CYP2C19 and CYP2C8. The main metabolic pathways include oxidation and O-dealkylation. The parent drug is the major circulating component, and metabolites are mostly inactive or less active.
Half-LifeThe elimination half-life is approximately 24 hours after repeated dosing, but this can vary between patients.
ExcretionThis medicine is eliminated mainly in the feces as unchanged drug and metabolites, with less than 2% excreted in the urine. The exact proportions may vary.
BioavailabilityThe absolute bioavailability is not well established from the available information. It is known to be incomplete and variable, and food can increase exposure.
Onset of ActionThe onset of anticancer effect is not immediate and is usually assessed over weeks to months of treatment. Symptomatic improvement, if any, may take several weeks.
Peak Plasma TimePeak plasma concentrations are generally reached about 3 to 4 hours after oral administration, but this can be delayed if taken with food.
Duration of ActionThe duration of action is related to the dosing interval. With once-daily dosing, the effect is sustained over 24 hours, but the full anticancer effect builds over time with repeated doses.

How It Works

This medicine is a reversible, small-molecule tyrosine kinase inhibitor that binds to the intracellular ATP-binding pocket of the epidermal growth factor receptor (EGFR/ErbB1) and human epidermal growth factor receptor 2 (HER2/ErbB2). By blocking the kinase activity of these receptors, it prevents autophosphorylation and downstream signaling through pathways such as MAPK and PI3K/AKT, which are important for cancer cell proliferation and survival. This leads to growth arrest and, in some cases, apoptosis of HER2-dependent cancer cells.

Mechanism Steps

1
Binding to the kinase domain: This medicine enters the cancer cell and binds reversibly to the ATP-binding site of the intracellular kinase domains of EGFR and HER2.
2
Blocking receptor autophosphorylation: By occupying the ATP pocket, it prevents the receptor from phosphorylating itself and its partner molecules.
3
Inhibition of downstream signaling: This blocks signals through the MAPK and PI3K/AKT pathways, which are needed for cancer cell growth and survival.
4
Growth arrest and cell death: As a result, cancer cells stop dividing and may undergo programmed cell death, leading to reduced tumor growth.

💡 How to Take bretolap tablet

Strength: Immediate-release tablet containing 250 mg of lapatinib.

1Take this medicine at the same time each day, with or without food.
2Swallow the tablet whole with a full glass of water. Do not crush, chew, or split the tablet.
3Avoid taking it with grapefruit or grapefruit juice.
4If you take acid-reducing medicines, take this medicine at least 1 hour before or 2 hours after them.
5If you miss a dose, follow the missed dose instructions. Do not double the dose.
6Keep a record of your doses and any side effects to discuss with your doctor.
7Do not stop taking this medicine without talking to your oncologist first.

Dosage Information

Adult DosageThe usual adult dose of this medicine is 1,250 mg (five 250 mg tablets) taken once daily on days 1 to 21 continuously in combination with capecitabine, or 1,500 mg (six 250 mg tablets) once daily when used with letrozole. The dose may be reduced by your doctor if you have side effects or liver problems. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function, and other medicines you are taking. Do not change the dose without medical advice.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly DosageNo specific dose adjustment is recommended for elderly patients based on age alone. However, elderly patients may be more sensitive to side effects, especially diarrhea, dehydration, and heart problems. Close monitoring is advised.
Renal ImpairmentNo dose adjustment is needed for mild to moderate kidney impairment. There is limited information for severe kidney impairment. Use with caution and monitor closely.
Hepatic ImpairmentFor patients with moderate liver impairment (Child-Pugh class B), the dose should be reduced. For severe liver impairment (Child-Pugh class C), this medicine is contraindicated. Your doctor will decide the appropriate dose based on your liver function tests.
Maximum Daily DoseThe maximum recommended daily dose is 1,500 mg once daily, but this depends on the specific combination regimen and your doctor's instructions. Do not exceed the prescribed dose.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With or without food
Take at the same time each day
Food can increase absorption, so consistency helps maintain steady blood levels.
Grapefruit and grapefruit juice
Avoid
Increases the blood levels of this medicine and the risk of side effects.
High-fat meals
Be consistent
A high-fat meal can increase absorption. If you take it with food, do so consistently.
St. John's wort
Avoid
Decreases the effectiveness of this medicine.

⏰ What to Do If You Miss a Dose

📌 Less than 12 hours have passed since the missed dose
→ Take the missed dose as soon as you remember.
💡 Continue with your regular schedule.
📌 More than 12 hours have passed since the missed dose
→ Skip the missed dose.
💡 Do not double the next dose to catch up.
📌 You are unsure what to do
→ Contact your doctor or pharmacist for advice.
💡 Never take two doses at the same time.

⚠️ Side Effects of bretolap tablet

✅ Common Side Effects

Diarrhea (Very common (more than 10%))
Drink plenty of fluids, use oral rehydration solutions, and tell your doctor if you have more than four loose stools in a day or if you feel dizzy or weak.
Nausea and vomiting (Common (1-10%))
Take the tablet with food if it helps, and ask your doctor about anti-nausea medicines. Report if you cannot keep fluids down.
Rash (Very common (more than 10%))
Use gentle skin care, avoid harsh soaps, and tell your doctor if the rash becomes severe or blisters.
Dry skin and itching (Common (1-10%))
Use moisturizers and avoid scratching. Report if itching is severe or if the skin breaks.
Mouth sores (Common (1-10%))
Rinse your mouth with salt water or a mild mouthwash, avoid spicy foods, and tell your doctor if you cannot eat or drink.
Tiredness (Common (1-10%))
Rest when needed, stay hydrated, and report if fatigue is severe or sudden.
Loss of appetite (Common (1-10%))
Eat small frequent meals and drink nutritious fluids. Tell your doctor if you lose weight.
Headache (Common (1-10%))
Rest and stay hydrated. Ask your doctor before taking any painkiller.

🚨 Serious Side Effects

Severe diarrhea with dehydration (Uncommon (0.1-1%))
Seek immediate medical attention if you have more than six loose stools in a day, cannot drink fluids, or feel very weak or dizzy.
Decreased heart pumping function (left ventricular dysfunction) (Uncommon (0.1-1%))
Report shortness of breath, swelling of the legs, or unusual tiredness immediately. Your doctor may check your heart function with an echocardiogram or MUGA scan.
Liver injury (hepatotoxicity) (Uncommon (0.1-1%))
Report yellowing of the eyes or skin, dark urine, right upper abdominal pain, or severe tiredness immediately. Regular liver blood tests are needed.
Severe skin reactions (Rare (less than 0.1%))
Seek immediate medical attention if you develop blistering, peeling skin, sores in the mouth or eyes, or a rash that spreads quickly.
Lung inflammation (pneumonitis) (Rare (less than 0.1%))
Report new or worsening cough, shortness of breath, or fever immediately.
Low white blood cell count with infection (Uncommon (0.1-1%))
Report fever, chills, sore throat, or any signs of infection promptly. Blood tests will monitor your counts.

⚠️ Rare Side Effects

Severe allergic reaction (anaphylaxis)
Seek emergency help if you have swelling of the face, lips, tongue, or throat, difficulty breathing, or a sudden severe rash.
Interstitial lung disease
Report persistent cough, breathlessness, or fever to your doctor immediately.
Pancreatitis
Seek medical attention for severe upper abdominal pain that may spread to the back, with nausea and vomiting.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ketoconazole Major
Rifampicin Major
Grapefruit juice Major
Omeprazole Moderate
Amiodarone Major
Digoxin Moderate
Midazolam Moderate
St. John's wort Major
Warfarin Moderate
Phenytoin Major

🚨 Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, grapefruit juice)
  • Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin, St. John's wort)
  • Drugs that prolong QT interval (e.g., amiodarone, sotalol, some antipsychotics)
  • Proton pump inhibitors (e.g., omeprazole) and H2 blockers (e.g., ranitidine)

⚡ Moderate Interactions

  • CYP3A4 substrates with narrow therapeutic index (e.g., midazolam, triazolam)
  • CYP2C8 substrates (e.g., repaglinide)
  • P-glycoprotein substrates (e.g., digoxin)

🍷 Alcohol Interaction

Alcohol may increase the risk of liver problems and stomach upset while taking this medicine. It is best to avoid alcohol or limit it as advised by your doctor.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known severe hypersensitivity to lapatinib or any component of the tablet.","Severe hepatic impairment (Child-Pugh class C).","Pregnancy or breastfeeding.","Use with strong CYP3A4 inhibitors or inducers should be avoided or managed with dose adjustment.","Patients with uncontrolled heart disease or recent heart attack should use with caution and only after cardiology evaluation."]

⚠️ Warnings & Precautions

["This medicine can cause severe diarrhea. Start antidiarrheal treatment early and drink plenty of fluids. Report diarrhea that does not improve or is accompanied by dizziness or weakness.","Liver injury can occur. Report yellowing of the eyes or skin, dark urine, or right upper abdominal pain immediately. Regular liver tests are required.","Heart function can decrease. Report shortness of breath, swelling of the legs, or unusual tiredness. Heart function tests are needed before and during treatment.","Severe skin reactions can occur. Report blistering, peeling, or sores in the mouth or eyes immediately.","Lung inflammation is rare but serious. Report new or worsening cough, shortness of breath, or fever.","This medicine can interact with many other medicines. Always tell your doctor about all medicines, supplements, and herbal products you are taking.","Do not take this medicine with grapefruit or grapefruit juice.","Use effective contraception during treatment and for at least one week after the last dose.","Do not breastfeed while taking this medicine.","Avoid live vaccines during treatment.","This medicine may cause tiredness or dizziness. Use caution when driving or operating machinery until you know how it affects you."]

🤱 Lactation Safety

It is not known whether this medicine passes into breast milk. Because of the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for at least one week after the last dose.

💊 Overdose Management

There is no specific antidote for an overdose of this medicine. If an overdose is suspected, seek emergency medical attention immediately. Treatment should be supportive and symptomatic, with close monitoring of vital signs, liver function, heart function, and blood counts. Gastric lavage may be considered if the overdose was recent and the patient is stable. Contact a poison control center if available.

⏰ Missed Dose

If you miss a dose, take it as soon as you remember if it is more than 12 hours before your next scheduled dose. If it is less than 12 hours before your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose.

Additional Safety Advice

General Safety

This medicine must only be taken under the supervision of a qualified oncologist. Do not start, stop, or change the dose without medical advice. Take the tablet at the same time each day, with or without food, but avoid taking it with grapefruit or grapefruit juice because these can increase the amount of medicine in your body. Swallow the tablet whole with water; do not crush or chew it. Because this medicine can cause diarrhea, keep oral rehydration solutions at home and report more than four loose stools in a day to your doctor. Use effective contraception during treatment and for at least one week after the last dose if you are of childbearing potential. Do not breastfeed while taking this medicine. Avoid live vaccines during treatment. Tell your doctor about all other medicines, supplements, and herbal products you are taking, especially those that affect liver enzymes or stomach acid. Regular blood tests for liver function, heart function, and blood counts are essential. If you miss a dose, do not double the next dose. If you experience severe diarrhea, yellowing of the eyes or skin, dark urine, chest pain, shortness of breath, or swelling of the legs, seek medical attention immediately.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more sensitive to the side effects of this medicine, especially diarrhea, dehydration, heart problems, and liver toxicity. Close monitoring of liver and heart function is recommended. Dose adjustments may be needed based on kidney and liver function. Falls and fatigue should be managed carefully.

🤰 Pregnancy Planning (TTC)

This medicine can harm the unborn baby and is contraindicated during pregnancy. Women of childbearing potential should use effective contraception during treatment and for at least one week after the last dose. If you are planning pregnancy, discuss with your oncologist well in advance. Men with female partners of childbearing potential should also use effective contraception during treatment and for at least one week after the last dose.

🏥 Post-Surgery Considerations

If you are scheduled for surgery, inform your surgeon and anesthesiologist that you are taking this medicine. It may need to be stopped temporarily before surgery due to the risk of bleeding, infection, and heart problems. Your oncologist will advise on the timing of stopping and restarting the medicine. Wound healing may be affected, and close monitoring is needed after surgery.

🦷 Dental Procedures

Inform your dentist that you are taking this medicine before any dental procedure. Because this medicine can affect blood counts and increase infection risk, your dentist may need to take precautions. Dental work should be coordinated with your oncologist, especially if you have low white blood cell or platelet counts. Good oral hygiene is important to prevent mouth sores and infections.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy weight to support overall health during cancer treatment.
🥗
Eat small, frequent meals if you have nausea or loss of appetite.
😴
Stay well hydrated, especially if you have diarrhea.
💧
Use gentle skin care products and moisturizers to manage rash and dry skin.
🧘
Get adequate rest and pace your activities to manage fatigue.
🌞
Avoid alcohol to reduce the risk of liver problems.
🚭
Practice good hand hygiene and avoid crowds during flu season to reduce infection risk.
🥑
Keep a symptom diary to share with your doctor at each visit.

🏋️ Exercise Considerations

Mild to moderate exercise such as walking or yoga may help with fatigue and overall well-being, but you should avoid strenuous activity if you have diarrhea, dizziness, or heart symptoms. Always consult your doctor before starting any exercise program while on this medicine.

🥗 Diet Recommendations

Eat a balanced diet rich in fruits, vegetables, and whole grains.
Include lean proteins to help maintain strength.
Avoid grapefruit and grapefruit juice.
Limit spicy and greasy foods if you have diarrhea or nausea.
Drink plenty of fluids, especially oral rehydration solutions if you have diarrhea.
Avoid alcohol.
Consider small, frequent meals if your appetite is poor.

💼 Impact on Daily Work & Life

This medicine may cause tiredness, dizziness, or diarrhea, which can affect your ability to work or drive. You should avoid driving or operating heavy machinery until you know how this medicine affects you. Most patients can continue with light work and daily activities, but you may need to take time off during severe side effects or hospital visits. Discuss your work schedule with your doctor and employer to make necessary adjustments.

🛑 When to Stop This Medicine

Do not stop taking this medicine without consulting your oncologist. Your doctor may decide to stop treatment if the cancer progresses, if you develop serious side effects such as severe liver injury or heart failure, or if you cannot tolerate the medicine. If you experience any red-flag symptoms, contact your doctor immediately; they will advise whether to continue, reduce the dose, or stop the medicine.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to persistent diarrhea, skin changes, and fatigue. Regular monitoring of liver and heart function is essential because toxicity can develop over time. Some patients may experience chronic hand-foot syndrome or nail changes. The risk of heart failure and liver injury continues with prolonged use, so periodic testing is necessary. Your doctor will weigh the benefits of continued treatment against the risks and may adjust or stop the medicine if serious side effects occur.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Trastuzumab-based therapy

Another HER2-targeted treatment that may be used instead of or in combination with this medicine.

Evidence: Well-established
Pertuzumab plus trastuzumab and chemotherapy

A combination regimen for HER2-positive breast cancer.

Evidence: Well-established
Clinical trials

Participation in clinical trials of new HER2-targeted therapies may be an option.

Evidence: Varies
Supportive care

Pain management, nutritional support, and psychological support can complement cancer treatment.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided while taking this medicine because the immune system may be suppressed. Inactivated vaccines are generally safe, but consult your doctor before receiving any vaccine. Timing of vaccines should be discussed with your oncologist.

📦 Storage Guide

✅ DO

Store at room temperature between 15°C and 30°C.

❌ DON'T

Do not refrigerate or freeze.

✅ DO

Keep in the original container, tightly closed.

❌ DON'T

Do not transfer to unmarked containers.

✅ DO

Protect from light and moisture.

❌ DON'T

Do not store in the bathroom.

✅ DO

Keep out of reach of children and pets.

❌ DON'T

Do not use after the expiry date.

✈️ Traveling with This Medicine

When traveling, carry this medicine in its original packaging with the prescription label clearly visible. Bring a copy of your prescription and a letter from your doctor explaining that you are taking this medicine for cancer treatment. Keep the tablets in your carry-on luggage to avoid loss or temperature extremes. Store at room temperature and protect from light and moisture. If crossing time zones, continue taking your dose at the same interval as prescribed; discuss any adjustments with your oncologist. Check customs regulations for controlled or prescription medicines in your destination country. Carry enough supply for the entire trip and a little extra in case of delays.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 52-year-old woman with HER2-positive metastatic breast cancer
She was started on this medicine along with capecitabine after her cancer progressed on other treatments. Within the first two weeks, she developed mild diarrhea and a rash on her face. Her doctor advised her to start loperamide and use a gentle moisturizer. She also had her liver enzymes checked every month. After three months, her scans showed stable disease, and she was able to continue treatment with good quality of life.
💡 Lesson: Early recognition and management of side effects like diarrhea and rash can help patients stay on treatment and achieve better outcomes.
👤 A 61-year-old postmenopausal woman with hormone receptor-positive, HER2-positive metastatic breast cancer
She was prescribed this medicine with letrozole. Before starting, her doctor checked her heart function with an echocardiogram. During treatment, she experienced fatigue and mild nausea but no serious side effects. Her heart function remained stable, and her tumor shrank after six months. She emphasized the importance of regular blood tests and taking the medicine at the same time every day.
💡 Lesson: Regular monitoring of heart and liver function, along with adherence to the prescribed schedule, is key to safe and effective treatment.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working at the cellular level soon after you take it, but its full anticancer effect builds over weeks to months. Your doctor will assess response with regular scans and tests.

Q: Can I take this medicine with food?

A: Yes, you can take it with or without food, but it is best to take it the same way each day. Avoid grapefruit and grapefruit juice.

Q: What should I do if I miss a dose?

A: If you remember within 12 hours of the missed dose, take it as soon as you remember. If more than 12 hours have passed, skip the missed dose and continue with your regular schedule. Do not double the dose.

Q: Will this medicine cause hair loss?

A: This medicine is a targeted therapy and does not usually cause hair loss. Hair loss is more common with traditional chemotherapy.

Q: Can I stop taking this medicine if I feel better?

A: No, you should not stop taking this medicine without talking to your oncologist. Stopping early may allow the cancer to grow.

Q: Does this medicine affect my heart?

A: Yes, it can decrease heart pumping function in some patients. Your doctor will check your heart function before and during treatment.

Q: Can I take this medicine during pregnancy?

A: No, this medicine can harm the unborn baby. Use effective contraception during treatment and for at least one week after the last dose.

Q: What should I avoid while taking this medicine?

A: Avoid grapefruit and grapefruit juice, St. John's wort, and live vaccines. Tell your doctor about all other medicines and supplements you take.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my heart function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • Will I lose my hair?
  • Can I take this medicine with food?
  • How often do I need blood tests?
  • Can I take this medicine if I am pregnant?

🔄 Substitutes for bretolap tablet

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine is a traditional chemotherapy that causes hair loss.
    Fact: This medicine is a targeted therapy and does not usually cause hair loss. It works differently from traditional chemotherapy.
  • Myth: This medicine can be taken without regular blood tests.
    Fact: Regular blood tests for liver function, heart function, and blood counts are essential because this medicine can cause serious side effects.
  • Myth: This medicine can be taken with grapefruit juice.
    Fact: Grapefruit and grapefruit juice should be avoided because they can increase the levels of this medicine and cause more side effects.
  • Myth: This medicine can be stopped when you feel better.
    Fact: This medicine should only be stopped on the advice of your oncologist. Stopping early may allow the cancer to grow.

🔄 Alternative Options

Generic Alternatives

  • Lapatinib 250 mg tablet

Brand Alternatives

  • Bretolap tablet

📊 Comparison with Similar Medicines

[{"medicine":"Lapatinib","class":"Tyrosine kinase inhibitor","route":"Oral","main_use":"HER2-positive metastatic breast cancer","key_side_effects":"Diarrhea, rash, liver toxicity, heart toxicity"},{"medicine":"Trastuzumab","class":"Monoclonal antibody","route":"Intravenous or subcutaneous","main_use":"HER2-positive breast and gastric cancer","key_side_effects":"Heart toxicity, infusion reactions"},{"medicine":"Capecitabine","class":"Antimetabolite chemotherapy","route":"Oral","main_use":"Breast and colorectal cancer","key_side_effects":"Hand-foot syndrome, diarrhea, mouth sores"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory